Robert Olstein's CVS Position Overview
Robert Olstein (via Olstein Capital Management, L.P.) currently holds 56,000 shares of CVS Health Corporation (CVS) worth $4.44 M, representing 0.91% of the portfolio. First purchased in 2014-Q1, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Robert Olstein has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2019, adding 50,000 shares. Largest reduction occurred in Q4 2019, reducing 61,800 shares.
Analysis based on 13F filings available since 2013 Q2
Robert Olstein's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Robert Olstein
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -13,000 | Reduce 18.84% | 56,000 | $79.36 |
| Q3 2025 | -8,000 | Reduce 10.39% | 69,000 | $75.39 |
| Q2 2025 | -33,000 | Reduce 30.00% | 77,000 | $68.97 |
| Q1 2025 | -13,000 | Reduce 10.57% | 110,000 | $67.75 |
| Q4 2024 | -42,000 | Reduce 25.45% | 123,000 | $44.89 |
| Q3 2024 | +10,000 | Add 6.45% | 165,000 | $62.88 |
| Q2 2024 | +26,000 | Add 20.16% | 155,000 | $59.06 |
| Q1 2024 | -13,000 | Reduce 9.15% | 129,000 | $79.76 |
| Q4 2023 | -13,000 | Reduce 8.39% | 142,000 | $78.96 |
| Q3 2023 | +17,000 | Add 12.32% | 155,000 | $69.82 |
| Q2 2023 | +20,000 | Add 16.95% | 138,000 | $69.13 |
| Q1 2023 | +40,000 | Add 51.28% | 118,000 | $74.31 |
| Q4 2022 | +2,000 | Add 2.63% | 78,000 | $93.19 |
| Q2 2022 | -23,000 | Reduce 23.23% | 76,000 | $92.66 |
| Q1 2022 | -27,000 | Reduce 21.43% | 99,000 | $101.21 |
| Q4 2021 | -51,000 | Reduce 28.81% | 126,000 | $103.16 |
| Q3 2021 | -3,000 | Reduce 1.67% | 177,000 | $84.86 |
| Q1 2021 | +11,000 | Add 6.51% | 180,000 | $75.23 |
| Q4 2020 | +2,000 | Add 1.20% | 169,000 | $68.30 |
| Q3 2020 | +23,000 | Add 15.97% | 167,000 | $58.40 |
| Q1 2020 | +19,500 | Add 15.66% | 144,000 | $59.33 |
| Q4 2019 | -61,800 | Reduce 33.17% | 124,500 | $74.29 |
| Q3 2019 | +3,300 | Add 1.80% | 186,300 | $63.07 |
| Q2 2019 | +6,000 | Add 3.39% | 183,000 | $54.49 |
| Q1 2019 | +50,000 | Add 39.37% | 177,000 | $53.93 |
| Q4 2018 | -1,000 | Reduce 0.78% | 127,000 | $65.52 |
| Q3 2018 | -36,000 | Reduce 21.95% | 128,000 | $78.72 |
| Q2 2018 | -21,000 | Reduce 11.35% | 164,000 | $64.35 |
| Q1 2018 | +48,500 | Add 35.53% | 185,000 | $62.21 |
| Q4 2017 | +17,500 | Add 14.71% | 136,500 | $72.50 |
| Q3 2017 | -5,925 | Reduce 4.74% | 119,000 | $81.32 |
| Q2 2017 | +3,000 | Add 2.46% | 124,925 | $80.46 |
| Q1 2017 | -18,075 | Reduce 12.91% | 121,925 | $78.50 |
| Q4 2016 | +32,000 | Add 29.63% | 140,000 | $78.91 |
| Q3 2016 | +17,000 | Add 18.68% | 108,000 | $88.99 |
| Q2 2016 | +27,000 | Add 42.19% | 91,000 | $95.74 |
| Q4 2015 | +19,000 | Add 42.22% | 64,000 | $97.77 |
| Q3 2015 | -12,000 | Reduce 21.05% | 45,000 | $96.49 |
| Q1 2015 | -18,000 | Reduce 24.00% | 57,000 | $103.21 |
| Q4 2014 | -17,000 | Reduce 18.48% | 75,000 | $96.31 |
| Q1 2014 | +92,000 | New Buy | 92,000 | $74.86 |
Robert Olstein's CVS Health Corporation Investment FAQs
Robert Olstein first purchased CVS Health Corporation (CVS) in Q1 2014, acquiring 92,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Olstein has held CVS Health Corporation (CVS) for 48 quarters since Q1 2014.
Robert Olstein's largest addition to CVS Health Corporation (CVS) was in Q1 2014, adding 92,000 shares worth $6.89 M.
According to the latest 13F filing for Q4 2025, Robert Olstein's firm, Olstein Capital Management, L.P., owns 56,000 shares of CVS Health Corporation (CVS), valued at approximately $4.44 M.
As of the Q4 2025 filing, CVS Health Corporation (CVS) represents approximately 0.91% of Robert Olstein's publicly disclosed stock portfolio, making it one of their key holdings.
Robert Olstein's peak holding in CVS Health Corporation (CVS) was 186,300 shares, as reported at the end of Q3 2019.